期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

酪氨酸磷酸酯酶抑制剂对tau蛋白磷酸化作用的研究 被引量：2

Effects of tyrosine phosphatase inhibitor on tau phosphorylation in vivo
暂未订购
导出
摘要 目的 :探讨受体酪氨酸磷酸酯酶对大鼠海马tau蛋白磷酸化的影响。方法 :大鼠海马直接注射酪氨酸磷酸酯酶 (PTP)抑制剂钒酸钠 (PVN)或糖原合酶激酶 (GSK - 3)抑制剂氯化锂 (LiCl) ,2 4h后用免疫印迹和免疫组织化学方法检测大鼠海马tau蛋白磷酸化水平。结果 :PVN可以明显降低大鼠海马tau蛋白PHF - 1位点磷酸化水平 ,且比LiCl的作用强 (P <0 0 1) ,与LiCl联用使非磷酸化位点tau - 1明显增强 (P <0 0 5 ) ,总tau蛋白 (R111d)含量显著降低 (P <0 0 5 )。结论 :PTP抑制剂明显降低大鼠海马tau蛋白磷酸化 ,其机制可能与GSK - 3失活有关。 AIM: To explore the effect of receptor tyrosine kinase system mediated by phosphotyrosine phosphatase (PTP) on tau phosphorylation in rat hippocampus. METHODS: Pervanadate (PVN), inhibitor of PTP or inhibitor of glycogen synthase kinase-3 (GSK-3), LiCl were injected into rat hippocampus by stereotaxy technique. The level of tau phosphorylation was detected by Western blot and immunohistochemistry after 24 h of injection. RESULTS: PVN significantly inhibited tau phosphorylation at PHF-1 epitope and the inhibition of tau phosphorylation by PVN was stronger than that of LiCl (P<0.01),and tau-1 epitope non-phosphorylated tau increased significantly in LiCl+PVN group than in control group (P<0.05). The level of total tau determined by R111d was significantly lower in PVN and LiCl+PVN treated groups (P<0.05) than that in LiCl and control groups. CONCLUSION: Tyrosine phosphatase inhibitor inhibited tau phosphorylation of hippocampus in rats. The underlie mechanism might be at least partially through the inhibition of GSK-3. [
作者 周新文 吴惠亮 曹伟丽 马丽娟 王建枝
机构地区 华中科技大学同济医学院基础医学院
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2004年第7期1134-1137,共4页 Chinese Journal of Pathophysiology
基金 国家杰出青年科学基金资助项目 (No .3992 5 0 12 ) 国家自然科学基金资助项目 (No .30 170 2 2 1)
关键词 蛋白质酪氨酸磷酸酶 TAU蛋白质类 磷酰化 Protein tyrosine-phosphatase tau proteins Phosphorylation
分类号 R363 [医药卫生—病理学]
  • 相关文献

参考文献13

  • 1[1]Braak H, Giffing K, Braak E. Neuroanatomy of Alzheimer disease[J]. Alzheimer's Res, 1997,33(6) :235 - 247.
  • 2[2]Alonso A, Zaidi T, Novak M, et al. Hyperphosphorylation induces self- assembly of tau into tangles of paired helical filaments/straight filaments[J]. Proc Natl Acad Sci USA, 2001,98(12) :6923 - 6928.
  • 3[3]Sun W, Qureshi HY, Cafferty PW, et al. Glycogen synthase kinase - 3 beta is complexed with tau protein in brain microtubules[J]. J Biol Chem, 2002,277(14):11933- 11940.
  • 4[4]Leroy K, Boutajangout A, Authelet M, et al. The active form of glycogen synthase kinase- 3 beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease [J]. Acta Neuropathol, 2002, 103(2) :91 - 99.
  • 5[5]Mattson MP. Brain evolution and lifespan regulation: conservation of signal transduction pathways that regulate energy metabolism[J]. Mech Ageing Dev, 2002, 123(8):947-953.
  • 6[6]Hetman M, Hsuan SL, Habas A, et al. ERK1/2 antagonizes glycogen synthase kinase - 3 β - induced apoptosis in cortical neurons[J]. J Biochem, 2002, 277(35): 31963-31971.
  • 7[7]Garzon D, Yu G, Fahnestock M. A new brain- derived neurotrophic factor transcript and decrease in brain - derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex[J]. J Neurochem, 2002,82(5):1058- 1064.
  • 8[8]Liu F, Zaidi T, Iqbal K, et al. Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5[J]. Neuroscience, 2002, 115(3) :829 - 837.
  • 9[9]Delobel P, Flament S, Hamdane M, et al. Modelling Alzheimer - specific abnormal tau phosphorylation independently of GSK3 beta and PKA kinase activities[J]. FEBS Lett, 2002, 10,516 (1-3):151- 155.
  • 10[10]Wang JZ, Gong CX, Zaidi T, et al. Dephosphorylation of Alzheimer paired helical filaments by PP - 2A and PP - 2D [J] .J Biochem, 1995,270(9) :4854 - 4860.

同被引文献20

  • 1Feijoo C,Campbell DG,Jakes R,et al.Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38delta at Thr50 promotes microtubule assembly[J].J Cell Sci,2005,118(Pt 2):397-408.
  • 2Weaver CL,Espinoza M,Kress Y,et al.Conformational change as one of the earliest alterations of tau in Alzheimer's disease[J].Neurobiol Aging,2000,21(5):719-727.
  • 3Liu F,Iqbal K,Grundke-Iqbal I,et al.Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta[J].FEBS Lett,2002,530(1-3):209-214.
  • 4Hanger DP,Hughes K,Woodgett,et al.Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau:generation of paired helical filament epitopes and neuronal localisation of the kinase[J].Neurosci Lett,1992,147(1):58-62.
  • 5Zhang YJ,Xu YF,Liu YH,et al.Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation[J].FEBS Lett,2005,579(27):6230-6236.
  • 6Sun L,Liu SY,Zhou XW,et al.Inhibition of protein phosphatase 2A-and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats[J].Neuroscience,2003,118(4):1175-1182.
  • 7Liu R,Pei JJ,Wang XC,et al.Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms[J].J Neurochem,2005,94(5):1225-1234.
  • 8Liu SJ,Zhang JY,Li HL,et al.Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain[J].J Biol Chem,2004,279(48):50078-50088.
  • 9Hanger DP,Betts JC,Loviny TL,et al.New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry [J].J Neurochem,1998,71 (6):2465-2476.
  • 10Lovestone S,Hartley CL,Pearce J,et al.Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells:the effects on the organization and stability of microtubules[J].Neuroscience,1996,73(4):1145-1157.

引证文献2

二级引证文献5

中国病理生理杂志
2004年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部